Evidence map›Paper›PMID 40999336›Full record

ArticleBMC plant biology2025

Transcriptional landscape of Atractylodes chinensis contracting root rot.

Yingzhe Li, Yang Liu, Tian Zhang, Shuai Ma, Yueyue Wang, Chunhan Qiao, Yu Cao, Chunying Zhao

Abstract read
In one paragraph

Article in BMC plant biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Frontiers in pharmacology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yingzhe Li *Hebei Province Key Laboratory of Research and Development of Traditional Chinese Medicine, Institute of Chinese Materia Medica, Chengde Medical University, Chengde, 067000, Hebei, China.
Yang Liu *Laboratory of Gene Engineering and Genomics, School of Basic Medical Sciences, Chengde Medical University, Chengde, 067000, Hebei, China.
Tian Zhang *State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Shuai MaHebei Province Key Laboratory of Research and Development of Traditional Chinese Medicine, Institute of Chinese Materia Medica, Chengde Medical University, Chengde, 067000, Hebei, China.
Yueyue WangHebei Province Key Laboratory of Research and Development of Traditional Chinese Medicine, Institute of Chinese Materia Medica, Chengde Medical University, Chengde, 067000, Hebei, China.
Chunhan QiaoHebei Province Key Laboratory of Research and Development of Traditional Chinese Medicine, Institute of Chinese Materia Medica, Chengde Medical University, Chengde, 067000, Hebei, China.
Yu CaoHebei Province Key Laboratory of Research and Development of Traditional Chinese Medicine, Institute of Chinese Materia Medica, Chengde Medical University, Chengde, 067000, Hebei, China. yucao@cdmc.edu.cn.ORCID http://orcid.org/0000-0001-7187-0773
Chunying ZhaoHebei Province Key Laboratory of Research and Development of Traditional Chinese Medicine, Institute of Chinese Materia Medica, Chengde Medical University, Chengde, 067000, Hebei, China. zhaochunying1908@163.com.

Funding

Chengde Medical University Scientific Research Fund of Senior Talent 202104Chengde Medical University Scientific Research Fund of Senior Talent 202403Hebei Natural Science Foundation H2021406030Hebei Natural Science Foundation H2023406026Science Research Project of Hebei Education Department QN2022082
6 · The paper itself

Abstract

Atractylodes chinensis is among the most economically valuable medicinal plants, serving as the primary source of Atractylodis rhizoma. Its pharmacological activities in treating digestive and urinary disorders have been officially recognized in both the Chinese and Japanese Pharmacopoeias. Whereas, the natural scarcity of Atractylodes chinensis necessitates enhanced cultivation strategies, particularly targeting root rot resistance to ameliorate crop yield and sustainable production. This study implemented controlled cultivation of Atractylodes chinensis and collected rhizome samples exhibiting early-stage root rot symptoms, advanced necrosis, and healthy controls. Ultra-high throughput sequencing was employed to detect differentially expressed genes (DEGs). Key dysregulated genes under root rot infection were systematically screened through Reactome pathway enrichment analysis, followed by clarification of cascade signaling. Further findings were validated through chromosomal mapping, correlation analysis, co-expression profiling, and dynamic protein interaction studies. Four critical genes annotated as probable sucrose-phosphate synthase 3, UDP-glucose 6-dehydrogenase 1-like, UDP-D-apiose/UDP-D-xylose synthase 2, and granule-bound starch synthase 1 demonstrated incipient infection expression patterns. Their dysregulation correlated with reduced nodule formation, diminished nitrogenase activity, disrupted cell wall integrity, and elevated reactive oxygen species levels. Twenty-nine progressive DEGs revealed functional connections to critical physiological processes including one-carbon metabolism, transmethylation-feedback regulation, polarity along the adaxial-abaxial axis, and synthesis of amino acid and phytoalexin. Notably, ten DEGs exhibited continuous dysregulation throughout infection progression, coupled with impaired response to metal stresses, potassium loss, and pathogens infection. This investigation systematically delineates the stage-specific pathological gene network underlying Atractylodes chinensis root rot pathogenesis, providing molecular targets for future disease-resistant cultivar development.

Indexed as

AtractylodesPlant DiseasesPlant RootsTranscriptomeGene Expression ProfilingGene Expression Regulation, PlantAtractylodes chinensisCascade signalingDysregulated genesRoot rot

Identifiers

PMID40999336
PMCPMC12465743

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.